Research shows that a significant population of Americans have genetic vulnerabilities that increase their likelihood of misusing alcohol.  These individuals often struggle to control their drinking, at the risk of legal, social, professional, and health consequences. 

 

Though complete abstinence is the preferred response for many who have abused alcohol, some make repeated attempts to limit their drinking, with mixed results.  

 

The development of the opiate-blocking medication, Naltrexone, has created treatment options for a range of addictive illness, both substance and behavioral.  Say When utilizes Naltrexone in a behavior modification approach that diminishes the reward mechanism that drives alcohol misuse, making the goals of moderation or abstinence achievable.